Literature DB >> 23615033

Neuronal mechanisms and the treatment of motion sickness.

F Schmäl1.   

Abstract

The aim of this review is to provide an overview of the physiological basis, clinical picture and treatment options for motion sickness. Motion sickness is a well-known nausea and vomiting syndrome in otherwise healthy people. The physical signs of motion sickness occur in both humans and animals during travel by sea, automobile or airplane and in space. Furthermore, some other special situations, such as simulators, the cinema and video games, have been described as causing pseudomotion sickness. Children between 2 and 12 years old are most susceptible to motion sickness, and women are more frequently affected than men. Predisposing factors include menstruation, pregnancy, migraines and possibly a side difference in the mass of otoconia in the vestibular organs. Therapy is directed towards decreasing conflicting sensory input, accelerating the process of adaptation and controlling nausea and vomiting. To control these vegetative symptoms, scopolamine and antihistamines are the most effective drugs.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23615033     DOI: 10.1159/000350185

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  30 in total

Review 1.  The Neurophysiology and Treatment of Motion Sickness.

Authors:  Andreas Koch; Ingolf Cascorbi; Martin Westhofen; Manuel Dafotakis; Sebastian Klapa; Johann Peter Kuhtz-Buschbeck
Journal:  Dtsch Arztebl Int       Date:  2018-10-12       Impact factor: 5.594

2.  Effects of overshadowing on conditioned and unconditioned nausea in a rotation paradigm with humans.

Authors:  Ursula Stockhorst; Geoffrey Hall; Paul Enck; Sibylle Klosterhalfen
Journal:  Exp Brain Res       Date:  2014-06-24       Impact factor: 1.972

3.  In Reply.

Authors:  Andreas Koch
Journal:  Dtsch Arztebl Int       Date:  2019-03-08       Impact factor: 5.594

4.  Impact of a simulated gravity load for atmospheric reentry, 10 g for 2 min, on conscious mice.

Authors:  Hironobu Morita; Aoi Yamaguchi; Dai Shiba; Masaki Shirakawa; Satoru Takahashi
Journal:  J Physiol Sci       Date:  2017-02-09       Impact factor: 2.781

5.  Effects of motion sickness severity on the vestibular-evoked myogenic potentials.

Authors:  Cynthia G Fowler; Amanda Sweet; Emily Steffel
Journal:  J Am Acad Audiol       Date:  2014-10       Impact factor: 1.664

6.  Intracellular vomit signals and cascades downstream of emetic receptors: Evidence from the least shrew (Cryptotis parva) model of vomiting.

Authors:  Weixia Zhong; Nissar A Darmani
Journal:  Rem Open Access       Date:  2017-10-31

7.  Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system.

Authors:  Keith A Sharkey; Nissar A Darmani; Linda A Parker
Journal:  Eur J Pharmacol       Date:  2013-11-01       Impact factor: 4.432

8.  The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew).

Authors:  Longlong Tu; Zengbing Lu; Man P Ngan; Francis F Y Lam; Claudio Giuliano; Emanuela Lovati; Claudio Pietra; John A Rudd
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

9.  Fibrous myopathy induced by intramuscular injections of cyclizine.

Authors:  Rory James Tinker; Ryan Wiltshire; Daniel du Plessis; James B Lilleker
Journal:  BMJ Case Rep       Date:  2020-05-11

Review 10.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.